Work

Do patients indicated for lipid-lowering therapy experience CV mortality benefits with PCSK9i monotherapy when compared with statin therapy?

Year: 2024

Type: article

Source: Evidence-Based Practice

DOI: 10.1097/ebp.0000000000002305

Authors: Madeline Dillen, Jason Fine, Taylor Thompson, Marianne Koenig

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404073890

FWCI:

Cites: 3

Cited by:

Related to: 10